Victory Capital Management
PMD

Victory Capital Management’s Psychemedics Corporation PMD Stock Holding History

Victory Capital Management’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,990
Closed -$56K – 2820
2021
Q1 		$56K Buy
+8,990
New +$59.6K ﹤0.01% 2661
2020
Q2 		– Sell
-1,548
Closed -$10K – 3373
2020
Q1 		$10K Buy
+1,548
New +$13K ﹤0.01% 3315
2019
Q4 		– Sell
-882
Closed -$8K – 3363
2019
Q3 		$8K Buy
+882
New +$7.49K ﹤0.01% 3343

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's PMD Position: Q2 2021 in Review

Victory Capital Management sold out of Psychemedics Corporation (PMD) in Q2 2021, closing a stake of 8,990 shares — an estimated $56K sold.

Victory Capital Management first reported a position in PMD in Q3 2019 and held it in 3 quarters. The position peaked at $56K in Q1 2021. 28 funds tracked by Wall St. Rank hold PMD as of Q2 2021.

  • Victory Capital Management reported no remaining Psychemedics Corporation position as of Q2 2021 after selling out during the quarter.
  • Victory Capital Management sold 8,990 Psychemedics Corporation shares in Q2 2021, an estimated $56K.
  • Victory Capital Management first reported a position in Psychemedics Corporation in Q3 2019 and held it in 3 quarters.
  • Victory Capital Management's Psychemedics Corporation position peaked at $56K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q2 2021.

Based on Victory Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.